Spandix Life Sciences Private Limited
About Spandix Life Sciences Private Limited
Data last updated:
Spandix Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 07 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2018PTC110023. Its GSTIN is 37AAZCS8140F1ZR (Andhra Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ganga Venkata Nagesh Babu and Bannaravuri Ashok.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 79 2nd Floor 7th Cross Krishna Nagar K R Puram, Bangalore, Karnataka, India – 560036.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.3 Lakh. For the same year it recorded a net profit of ₹9,733 (net margin 0.2%) and EBITDA of ₹14,107 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 91% over three years and 61% over five years.
Company details
Contact details
Spandix Life Sciences Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered Address# 79 2nd Floor 7th Cross Krishna Nagar K R Puram, Bangalore, Karnataka, India – 560036
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Spandix Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spandix Life Sciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Spandix Life Sciences Private Limited, buy the company report.
Financials of Spandix Life Sciences Private Limited
FY 2025 filings availableSpandix Life Sciences Private Limited reported revenue of ₹41.3 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 61% over five years. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14,107 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,733 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spandix Life Sciences Private Limited, buy the company report.
Board of directors of Spandix Life Sciences Private Limited
Spandix Life Sciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganga Venkata Nagesh Babu | Director | 07 Feb 2018 | 8 Years 8 Months | Current |
| Bannaravuri Ashok | Director | 07 Feb 2018 | 8 Years 8 Months | Current |
| Sesha Sai Tiruveedhula | Director | 18 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Spandix Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HRN H-Bot Solutions Private Limited | ₹41.48 Lakh (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Him Pharmaceuticals Private Limited | ₹41.43 Lakh (FY 2024) | -1.0% | Surat, Gujarat, India | |||
| Halecaim Private Limited | ₹41.43 Lakh (FY 2025) | -67.0% | Bangalore, Karnataka, India | |||
| Vinsfertility Private Limited | ₹41.42 Lakh (FY 2021) | New Delhi, Delhi, India | ||||
| Megha Medtech Private Limited | ₹41.3 Lakh (FY 2025) | 48.0% | Chennai, Tamil Nadu, India | |||
| Spandix Life Sciences Private Limitedthis company | ₹41.3 Lakh (FY 2024) | ₹9,733 | 0.2% | Bangalore, Karnataka, India | ||
| Humanmovement Lab Private Limited | ₹41.29 Lakh (FY 2024) | 6.0% | Bangalore, Karnataka, India | |||
| Unomed Medical Enterprises Private Limited | ₹41.28 Lakh (FY 2023) | -51.0% | Payyannur, Kerala, India | |||
| Pacifyr Health and Wellness Private Limited | ₹41.27 Lakh (FY 2023) | 1015.0% | Chennai, Tamil Nadu, India | |||
| Netradeep Eyecare and Laser Centre Private Limited | ₹41.23 Lakh (FY 2025) | 20.0% | Surat, Gujarat, India | |||
| Charaya Healthcare Private Limited | ₹41.21 Lakh (FY 2025) | -44.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Spandix Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spandix Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spandix Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spandix Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAZCS8140F1ZR | Andhra Pradesh | Active | 26 Apr 2018 |
To see the full GST registrations and return filing status of Spandix Life Sciences Private Limited, buy the company report.
Recent activity
Spandix Life Sciences Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Sesha Sai Tiruveedhula was appointed as Director on 18 Nov 2025.
Frequently asked questions
Spandix Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in other services, within the business services industry. It was incorporated on 07 February 2018 (8+ years old) and is registered under CIN U74999KA2018PTC110023.
Spandix Life Sciences has 3 current directors:
- Ganga Venkata Nagesh Babu - Director
- Bannaravuri Ashok - Director
- Sesha Sai Tiruveedhula - Director
The latest financial statements of Spandix Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Spandix Life Sciences is 37AAZCS8140F1ZR, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Spandix Life Sciences is U74999KA2018PTC110023. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spandix Life Sciences was incorporated on 07 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Spandix Life Sciences by revenue are HRN H-Bot Solutions Private Limited, Him Pharmaceuticals Private Limited, Halecaim Private Limited, Vinsfertility Private Limited, Megha Medtech Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Sesha Sai Tiruveedhula was appointed as Director on 18 Nov 2025. Bannaravuri Ashok was appointed as Director on 07 Feb 2018. Ganga Venkata Nagesh Babu was appointed as Director on 07 Feb 2018.
The registered office of Spandix Life Sciences is at # 79 2nd Floor 7th Cross Krishna Nagar K R Puram, Bangalore, Karnataka, India – 560036.
Spandix Life Sciences operates in the business services industry, in the other services segment.
Spandix Life Sciences can be reached at its registered office: # 79 2nd Floor 7th Cross Krishna Nagar K R Puram, Bangalore, Karnataka, India – 560036.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
